Edition:
India

Ra Pharmaceuticals Inc (RARX.OQ)

RARX.OQ on NASDAQ Stock Exchange Global Market

14.04USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$14.04
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,424
52-wk High
$27.77
52-wk Low
$12.04

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.65 December 21 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.80 1.80 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 1.12 2.50 0.00 --
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 4 1.12 2.50 0.00 --
Year Ending Dec-18 3 27.50 80.50 0.00 --
Earnings (per share)
Quarter Ending Dec-17 5 -0.65 -0.42 -0.76 --
Quarter Ending Mar-18 1 -0.61 -0.61 -0.61 --
Year Ending Dec-17 5 -2.33 -1.90 -2.50 --
Year Ending Dec-18 5 -2.32 -0.10 -3.78 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.83 0.00 0.83 100.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 1.70 0.00 1.70 100.00
Earnings (per share)
Quarter Ending Sep-17 -0.63 -0.68 0.05 -7.29
Quarter Ending Jun-17 -0.51 -0.56 0.05 -8.74
Quarter Ending Mar-17 -0.59 -0.50 0.09 -15.33
Quarter Ending Dec-16 -0.47 -0.73 0.26 -54.99
Quarter Ending Sep-16 -0.72 -14.22 13.50 -1,881.88

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.12 1.12 1.12 1.12 --
Quarter Ending Mar-18 0.00 -- -- -- --
Year Ending Dec-17 1.12 1.12 1.12 1.12 --
Year Ending Dec-18 27.50 27.50 27.50 27.50 --
Earnings (per share)
Quarter Ending Dec-17 -0.65 -0.63 -0.63 -0.63 --
Quarter Ending Mar-18 -0.61 -- -- -- --
Year Ending Dec-17 -2.33 -2.31 -2.31 -2.31 --
Year Ending Dec-18 -2.32 -2.23 -2.23 -2.23 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 -- -- -- --
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 2 1 2 1
Quarter Ending Mar-18 -- -- -- --
Year Ending Dec-17 1 1 1 1
Year Ending Dec-18 1 3 1 3